| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.088 | 0.004 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.007 |